AKT1 and cancer: PI3K/AKT/mTOR pathway inhibitors combined with RT is a new method to enhance radiosensitivity and for treatment in some different cancers such as CC, and mTOR inhibitors possess a possible function to promote the efficacy of RT [18,89,90].